• Capricor Therapeutics Inc (NASDAQ:CAPR) Given Consensus Rating of "Buy" by Brokerages

    Source: Buzz FX / 20 Jan 2025 03:51:17   America/Chicago


    Capricor Therapeutics Inc (NASDAQ:CAPR) Given Consensus Rating of "Buy" by Brokerages Written by MarketBeat January 20, 2025 Share Link copied to clipboard. Capricor Therapeutics Inc ( NASDAQ:CAPR - Get Free Report ) has been assigned a con
    Read more...
Share on,